(PLRX) Pliant Therapeutics - Performance -89% in 12m
PLRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-84.20%
#148 in Peer-Group
Rel. Strength
1.37%
#7581 in Stock-Universe
Total Return 12m
-89.04%
#191 in Peer-Group
Total Return 5y
-94.07%
#143 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 15.70 USD |
| 52 Week Low | 1.16 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.66 |
| Buy/Sell Signal +-5 | 0.61 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PLRX (-89%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.14% | 63.4% | 78.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.5% | -7.13% | 36% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PLRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PLRX
| Total Return (including Dividends) | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.62% | 5.89% | 3.98% |
| 3 Months | 2.11% | 15.34% | 16.24% |
| 12 Months | -89.04% | -11.61% | 12.66% |
| 5 Years | -94.07% | -23.80% | 109.18% |
| Trend Score (consistency of price movement) | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.8% | 65.7% | 91.4% |
| 3 Months | -51.5% | 79.4% | 97.5% |
| 12 Months | -79.3% | -87.3% | 46.7% |
| 5 Years | -65.5% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th55.50 | 0.69% | 2.54% |
| 3 Month | %th28.50 | -11.46% | -12.15% |
| 12 Month | %th4.50 | -87.60% | -90.27% |
| 5 Years | %th29.00 | -92.22% | -97.17% |
FAQs
Does Pliant Therapeutics (PLRX) outperform the market?
No,
over the last 12 months PLRX made -89.04%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months PLRX made 2.11%, while XBI made 15.34%.
Performance Comparison PLRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PLRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 22.2% | 2.6% | -95.1% | -102% |
| US NASDAQ 100 | QQQ | 22.1% | 2.4% | -97.5% | -102% |
| German DAX 40 | DAX | 22.5% | 4.7% | -105.7% | -118% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 20.7% | 1.5% | -97% | -109% |
| Hongkong Hang Seng | HSI | 21.4% | 4.1% | -116.4% | -123% |
| India NIFTY 50 | INDA | 23.7% | 6% | -94.9% | -86% |
| Brasil Bovespa | EWZ | 27.4% | 10.2% | -108.2% | -89% |
PLRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.8% | 3.8% | -99.8% | -114% |
| Consumer Discretionary | XLY | 21.1% | 2.6% | -87.9% | -106% |
| Consumer Staples | XLP | 24.4% | 6.4% | -94.1% | -97% |
| Energy | XLE | 20.6% | 5.5% | -85.3% | -88% |
| Financial | XLF | 23.1% | 2.3% | -96.8% | -113% |
| Health Care | XLV | 22.4% | 6.7% | -84.4% | -82% |
| Industrial | XLI | 21.5% | 1.2% | -100.1% | -112% |
| Materials | XLB | 22.3% | 2.8% | -93.7% | -92% |
| Real Estate | XLRE | 22% | 5.9% | -93.3% | -97% |
| Technology | XLK | 22.6% | 1.3% | -99.7% | -99% |
| Utilities | XLU | 21.9% | 3.7% | -98% | -112% |
| Aerospace & Defense | XAR | 19.8% | -3.3% | -115.6% | -139% |
| Biotech | XBI | 17.3% | 0.7% | -89% | -77% |
| Homebuilder | XHB | 20.1% | -2.7% | -84.8% | -85% |
| Retail | XRT | 21.8% | 1.5% | -91.8% | -96% |
PLRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 24% | 10.4% | -79.7% | -83% |
| Natural Gas | UNG | 21.7% | 16.6% | -69.9% | -95% |
| Gold | GLD | 22.7% | 7.8% | -111.8% | -127% |
| Silver | SLV | 19.3% | 1.8% | -114.4% | -113% |
| Copper | CPER | 12.8% | -6.9% | -112.9% | -111% |
PLRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 23.5% | 6.1% | -89.7% | -85% |
| iShares High Yield Corp. Bond | HYG | 22.9% | 5.4% | -91.9% | -98% |